Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2025-12-27 @ 11:32 AM
Study NCT ID:
NCT05113459
Status:
UNKNOWN
Last Update Posted:
2021-11-09
First Post:
2021-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer（RC48-C018）
Sponsor:
Guoxin Li
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-18
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-12-18
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-06-18
Completion Date Type:
ESTIMATED
First Submit Date:
2021-11-02
First Submit QC Date:
None
Study First Post Date:
2021-11-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-08
Last Update Post Date:
2021-11-09
Last Update Post Date Type:
ACTUAL